Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer

To investigate systemic regulators of the cancer-associated cachexia syndrome (CACS) in a pre-clinical model for lung cancer with the goal to identify therapeutic targets for tissue wasting.